NEW YORK ― Transcranial magnetic stimulation (TMS) is a cost-effective treatment option for patients with resistant major depressive disorder (MDD), according to a new economic analysis. "It's mainly ...

Repetitive transcranial magnetic stimulation (rTMS) is associated with reduced symptom severity in patients with comorbid major depressive disorder (MDD) and substance use disorders (SUDs), new ...

Expert behavioral medicine specialists and neurologists at the WVU Rockefeller Neuroscience Institute (RNI) offer an alternative and complementary treatment option for adult patients who have major ...

SAN ANTONIO — Poster data presented here at the U.S. Psychiatric and Mental Health Congress indicated efficacy of NeuroStar transcranial magnetic stimulation for postpartum depression. “Postpartum ...

Preliminary unaudited fourth quarter and full year revenue 2024 was $22.1 and $74.5, respectively Closed acquisition of Greenbrook TMS effective as of December 9, 2024 Expects full year 2025 pro forma ...